Epidural volume may change pain relief quality in labor

NCT ID NCT07684365

Not yet recruiting Symptom relief Sponsor: Beth Israel Deaconess Medical Center Source: ClinicalTrials.gov ↗

First seen Jul 06, 2026 · Last updated Jul 07, 2026 · Updated 1 time

Summary

This trial investigates whether the volume and concentration of medication given through an epidural affect how well it relieves labor pain and what side effects occur. Pregnant women at 36 weeks or more, in early labor or being induced, receive the same dose of bupivacaine and fentanyl but in different volumes. Researchers track how often women need extra pain relief to see which approach works best.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: bupivacaine and fentanyl
What this could lead to: If it works, this could help tailor epidural doses to improve pain relief and reduce side effects for women in labor.
What could go wrong: This is a small, single-center study focused on short-term outcomes, so results may not apply to all hospitals or patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates